Z

Zomedica Corp
AMEX:ZOM

Watchlist Manager
Zomedica Corp
AMEX:ZOM
Watchlist
Price: 0.142693 USD 16.96% Market Closed
Market Cap: 139.8m USD
Have any thoughts about
Zomedica Corp?
Write Note

Zomedica Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zomedica Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zomedica Corp
AMEX:ZOM
Revenue
$26.1m
CAGR 3-Years
856%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%

Zomedica Corp
Revenue Breakdown

Breakdown by Geography
Zomedica Corp

Not Available

Breakdown by Segments
Zomedica Corp

Total Revenue: 25.2m USD
100%
Therapeutic Devices: 23.8m USD
94.5%
Revenue Classified As Consumables: 16.3m USD
64.8%
Revenue Classified As Capital: 8.8m USD
34.9%
Diagnostics: 1.4m USD
5.5%
Other: 85k USD
0.3%
Show More
Show Less

See Also

What is Zomedica Corp's Revenue?
Revenue
26.1m USD

Based on the financial report for Jun 30, 2024, Zomedica Corp's Revenue amounts to 26.1m USD.

What is Zomedica Corp's Revenue growth rate?
Revenue CAGR 3Y
856%

Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Zomedica Corp have been 856% over the past three years .

Back to Top